This campaign has been commissioned by an international Japanese pharmaceutical company who combat diseases with a combination of ground‐breaking technology and biology, with an extensive track record of academic collaboration. They are seeking promising drug targets or drug candidates that are secured by human genetic information and are unprecedented (i.e. no competitors are reported).
Nov
28
Comments are closed.